- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare ICICI Prudential Nifty Pharma Index Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹1000 | ₹500 |
Expense Ratio | 0.97 | 1.94 |
NAV | ₹16.06 | ₹413.26 |
Fund Started | 25 Nov 2022 | 04 Jun 1999 |
Fund Size | ₹80.60 Cr | ₹3610.51 Cr |
Exit Load | - | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹1000
₹500
Expense Ratio
0.97
1.94
NAV
₹16.06
₹413.26
Fund Started
25 Nov 2022
04 Jun 1999
Fund Size
₹80.60 Cr
₹3610.51 Cr
Exit Load
-
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 12.37% | 20.37% |
3 Year | - | 22.50% |
5 Year | - | 25.09% |
1 Year
12.37%
20.37%
3 Year
-
22.50%
5 Year
-
25.09%
Holding Analysis
Equity | 99.32% | 96.93% |
Cash | 0.68% | 2.99% |
Equity
99.32%
96.93%
Cash
0.68%
2.99%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 24.74% |
Cipla Ltd. | 10.73% |
Divi's Laboratories Ltd. | 9.70% |
Dr. Reddy's Laboratories Ltd. | 9.23% |
Lupin Ltd. | 6.48% |
Torrent Pharmaceuticals Ltd. | 4.46% |
Aurobindo Pharma Ltd. | 4.29% |
Mankind Pharma Ltd. | 3.62% |
Alkem Laboratories Ltd. | 3.43% |
Laurus Labs Ltd. | 3.18% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.45% |
Max Healthcare Institute Ltd. | 6.68% |
Divi's Laboratories Ltd. | 6.00% |
Cipla Ltd. | 4.79% |
Lupin Ltd. | 4.72% |
Lonza Group Ag | 4.38% |
Mankind Pharma Ltd. | 3.76% |
Krishna Institute of Medical Sciences Ltd | 3.72% |
Jupiter Life Line Hospitals Ltd. | 3.54% |
Ami Organics Ltd. | 3.38% |
Fund Manager
Name | Kayzad Eghlim | Tanmaya Desai |
Start Date | 03 Dec 2021 | 27 Jun 2011 |
Name
Kayzad Eghlim
Tanmaya Desai
Start Date
03 Dec 2021
27 Jun 2011
About Fund
Description | The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 25 Nov 2022 | 04 Jun 1999 |
Description
The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
25 Nov 2022
04 Jun 1999